Nuwellis, Inc. (NUWE) Stock Analysis & Investment Frameworks
Nuwellis, Inc. (NUWE) stock analysis on Invetso. Review Nuwellis, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Nuwellis, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Nuwellis, Inc. Key Financial Metrics
- Market Cap: $71364.00
- Revenue: $8.27M
- ROE: -605.75%
- ROIC: -238.32%
- Dividend Yield: N/A
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc. Investment Frameworks
Invetso analyzes Nuwellis, Inc. (NUWE) across the following frameworks:
- Nuwellis, Inc. 10Y Growth Potential
- Nuwellis, Inc. Scenario Analysis
- Nuwellis, Inc. Risks & Opportunities
- Nuwellis, Inc. Economic Moat
- Nuwellis, Inc. Business Model
- Nuwellis, Inc. Management
- Nuwellis, Inc. SWOT Analysis
- Nuwellis, Inc. Porter's 5 Forces
- Nuwellis, Inc. PESTLE Analysis
- Nuwellis, Inc. ESG Analysis